Case Western Reserve University research finds drug candidate slows age-relat…
Research results from the Case Western Reserve University School of Medicine show that the progression of age-related macular degeneration is markedly slowed in new laboratory-engineered mice when they received treatments of retinylamine, a trial drug that has been tested in a medical school lab. AMD is a leading cause of vision loss in Americans 60 years of age and older.The findings from the National Eye Institute-funded research are reported in the prestigious Journal of Biological Chemistry.
More: continued here